Squamous cell carcinoma antigen in human liver carcinogenesis

Area of Science:

• Hepatobiliary pathology
• Cancer biomarker research
• Molecular diagnostics

Background:

• Squamous cell carcinoma antigen (SCCA) is overexpressed in hepatocellular carcinoma (HCC).
• Previous research lacked data on SCCA expression in pre-malignant liver lesions.
• Understanding early molecular changes is crucial for HCC prevention and treatment.

Purpose of the Study:

• To investigate SCCA expression in HCC and its precursor lesions within cirrhotic livers.
• To utilize immunohistochemistry for precise localization and quantification of SCCA.
• To establish SCCA as a potential early diagnostic marker for liver cancer.

Main Methods:

• Examined 55 liver nodules (7 LRNs, 7 LG-DNs, 10 HG-DNs, 31 HCC) from 42 explanted cirrhotic livers.
• Employed semiquantitative immunohistochemistry to score SCCA expression on a four-tiered scale.
• Analyzed SCCA expression patterns, including cellular distribution and staining intensity.

Main Results:

• SCCA was detected in the cytoplasm of hepatocytes, primarily with a granular pattern.
• Prevalence of SCCA expression was 29% in LRNs, 100% in DNs, and 93% in HCC.
• Significant differences in SCCA expression were observed between LRNs and all other nodule types, and between cirrhotic tissue adjacent to HCC and LRNs.

Conclusions:

• Aberrant SCCA expression represents an early event in the transformation of liver cells towards malignancy.
• SCCA's presence in dysplastic nodules suggests its potential as an early biomarker for HCC.
• Further research into SCCA's role can inform targeted therapies and early detection strategies.